Global Flexible Manufacturing Systems in the Pharmaceutical Industry Market (2021 to 2026) - Rising Opportunities with Industry 4.0 and Pharma 4.0
October 26, 2021 07:23 ET
|
Research and Markets
Dublin, Oct. 26, 2021 (GLOBE NEWSWIRE) -- The "Global Market for Flexible Manufacturing Systems in the Pharmaceutical Industry" report has been added to ResearchAndMarkets.com's offering. This...
Josh Wilhelm Joins PetVivo Holdings, Inc. as the Director of Manufacturing
September 08, 2021 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Sept. 08, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative...
Psychedelic Joint Venture Between Mycotopia Therapies and Natural MedTech Brings Research and Drug Development to Test Active Ingredient In Psychedelics
March 22, 2021 07:00 ET
|
20/20 Global, Inc.
MIAMI, March 22, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc. dba Mycotopia Therapies, (OTC Pink: TWGL) (the “Company”), a company focused on psychedelic therapies, announced today it has formed...
Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing
March 08, 2021 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, March 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Cytovance Biologics offers Nature Technology Corporation’s proprietary HyperGRO™ manufacturing platform for plasmid DNA CGMP manufacturing
November 30, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
Provectus Biopharmaceuticals Highlights Stage IV M1c Patient Outcome from Combination Therapy Trial of PV-10® and KEYTRUDA® for Checkpoint-Naïve Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020
September 21, 2020 12:45 ET
|
Provectus Biopharmaceuticals Inc.
Near-resolution of tumor burden, including extensive visceral hepatic diseaseExpanded data set of trial subject provided KNOXVILLE, TN, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT)...
Global CDMO Industry Insights Report 2019-2025: Market Size Breakdown by Type of Service, Type of Molecule, End Use and Region
September 02, 2020 05:19 ET
|
Research and Markets
Dublin, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The "Global Market Opportunities and Competitive Landscape for CDMO" report has been added to ResearchAndMarkets.com's offering. This report provides an...
Provectus Biopharmaceuticals Expands Sponsored Research Collaboration with University of Calgary (Canada) to Investigate Oral Administration of Rose Bengal Disodium for Cancer Treatment
August 13, 2020 08:00 ET
|
Provectus Biopharmaceuticals Inc.
University of Calgary researchers have successfully demonstrated initial, in vivo proof-of-concept, oral rose bengal disodium treatment for blood cancerResearchers will now investigate oral treatment...
Open Book Extracts Enters South Africa Market with Strategic Distribution Partner, Strengthening Global Reach
July 31, 2020 08:33 ET
|
Open Book Extracts
ROXBORO, N.C., July 31, 2020 (GLOBE NEWSWIRE) -- With demand increasing for quality, high-purity cannabinoid ingredients like CBD, THCV and CBN globally, leading cannabinoid-based health and...
Cytovance Biologics Announces an Investment in Mass Spectrometry Services
July 15, 2020 03:00 ET
|
Cytovance Biologics
OKLAHOMA CITY, July 15, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the addition of Mass...